Industry reports
Editor highlights

Search inside this page

Free Market Research Guides to Download

Biological Therapy Analysis & Statistics, April 2012 (p9)

You might be interested in: stem cell, cell therapy, tissue engineering, more »

» Purchase Premium Reports

241-270 of about 400 reports
Biological Therapy Industry: Plasma Cell Neoplasm - Pipeline Review, H1 2012

Biological Therapy Industry: Plasma Cell Neoplasm - Pipeline Review, H1 2012

  • $ 500
  • Company report
  • April 2012
  • by Global Markets Direct

This report provides data on the therapeutic development for Plasma Cell Neoplasm, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...

  • Industries : Biological Therapy
Global RNA Interference (RNAi) Industry

Global RNA Interference (RNAi) Industry

  • $ 4 800
  • Industry report
  • April 2012
  • by Global Industry Analyst

This report analyzes the worldwide markets for RNA Interference (RNAi) in US$ Million by the following Application Areas: Drug Discovery and Target Validation, Reagents, and siRNA Synthesis. The report ...

  • Industries : Biological Therapy
  • Countries : World
Human Stem Cell Banks in the US - Industry Market Research Report

Human Stem Cell Banks in the US - Industry Market Research Report

  • $ 1 020
  • Industry report
  • April 2012
  • by Ibisworld

Human Stem Cell Banks Human stem cell banks collect, test, preserve and deliver stem cells from donors either for preparation of cell lines for use in research, or for future use through banking umbilical ...

  • Industries : Biological Therapy
  • Countries : United States
Global RNAi Market Analysis

Global RNAi Market Analysis

  • $ 1 200
  • Industry report
  • April 2012
  • by RNCOS

RNA Interference (RNAi) has emerged as a breakthrough in the life sciences industry. It presents an extensive potential in multiple areas, such as drug discovery, drug development, and therapeutic applications ...

  • Industries : Biological Therapy
  • Countries : World
Pathfinder Cell Therapy, Inc. (SYMD) - Financial and Strategic SWOT Analysis Review

Pathfinder Cell Therapy, Inc. (SYMD) - Financial and Strategic SWOT Analysis Review

  • $ 250
  • Company report
  • March 2012
  • by Global Data

Pathfinder Cell Therapy, Inc. (Pathfinder Cell Therapy), formerly known as SyntheMed, Inc., is a biomaterial company principally engaged in the development and distribution of anti-adhesion surgical products. ...

  • Industries : Biological Therapy
  • Countries : United States
Stem Cell Sciences Plc (Symbol:STEM) SWOT Analysis, Strategy, Revenues and Profits

Stem Cell Sciences Plc (Symbol:STEM) SWOT Analysis, Strategy, Revenues and Profits

  • $ 250
  • Company report
  • March 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
Stem Cell Innovations, Inc. (Symbol:SCLL) SWOT Analysis, Strategy, Revenues and Profits

Stem Cell Innovations, Inc. (Symbol:SCLL) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • March 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
Chemokine Therapeutics Corp. (Symbol:CTI) SWOT Analysis, Strategy, Revenues and Profits

Chemokine Therapeutics Corp. (Symbol:CTI) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • March 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : Canada, United Kingdom
Genitope Corporation (Symbol:GTOP) SWOT Analysis, Strategy, Revenues and Profits

Genitope Corporation (Symbol:GTOP) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • March 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
Forticell Bioscience, Inc. (Symbol:FORBQ) SWOT Analysis, Strategy, Revenues and Profits

Forticell Bioscience, Inc. (Symbol:FORBQ) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • March 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
Biologics Market in Brazil

Biologics Market in Brazil

  • $ 6 000
  • Industry report
  • March 2012
  • by Frost & Sullivan

This research service considers the biologics market in Brazil. It covers the market's move toward greater regulation and outlines the impact of specific patent expirations. An analysis of monoclonal antibodies, ...

  • Industries : Biological Therapy
  • Countries : Brazil
Fibrocell Sciences, Inc. (ILEIQ) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Fibrocell Sciences, Inc. (ILEIQ) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • March 2012
  • by Global Data

Fibrocell Sciences, Inc. (ILEIQ) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary Fibrocell Sciences, Inc. (Fibrocell), formerly Isolagen, Inc., is an aesthetic and therapeutic development ...

  • Industries : Biological Therapy
  • Countries : United States
Pathfinder Cell Therapy, Inc. (SYMD) - Medical Equipment - Deals and Alliances Profile

Pathfinder Cell Therapy, Inc. (SYMD) - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • March 2012
  • by Global Data

Pathfinder Cell Therapy, Inc. (SYMD) - Medical Equipment - Deals and Alliances Profile Summary Pathfinder Cell Therapy, Inc. (Pathfinder Cell Therapy), formerly known as SyntheMed, Inc., is a biomaterial ...

  • Industries : Biological Therapy
Global Gene Therapy Industry

Global Gene Therapy Industry

  • $ 4 500
  • Industry report
  • February 2012
  • by Global Industry Analyst

This report analyzes the Global market for Gene Therapy in US$ Million. Annual estimates and forecasts are provided for the period 2009 through 2017. The report profiles 98 companies including many key ...

  • Industries : Biological Therapy
  • Countries : World
Global Tissue Engineering and Regeneration Market 2011-2015

Global Tissue Engineering and Regeneration Market 2011-2015

  • $ 1 500
  • Industry report
  • February 2012
  • by Infiniti Research Limited

TechNavio's analysts forecast the Global Tissue Engineering and Regeneration market to grow at a CAGR of 8.5 percent over the period 2011-2015. One of the key factors contributing to this market growth ...

  • Industries : Biological Therapy
  • Countries : World
RNA Interference Therapy in Oncology Drug Pipeline Update 2012

RNA Interference Therapy in Oncology Drug Pipeline Update 2012

  • $ 1 499
  • Company report
  • February 2012
  • by Bioseeker

Potentially any disease-causing gene, cell type or tissue can be targeted with RNAi, including those not 'druggable' with small molecules or protein-based therapies. There are today 43 companies plus partners ...

  • Industries : Biological Therapy
Emerging Tumor Markers and Companies Developing Innovative Technologies and Products

Emerging Tumor Markers and Companies Developing Innovative Technologies and Products

  • $ 2 850
  • Industry report
  • February 2012
  • by Venture Planning Group

Highlights Comprehensive 260-page market and technological assessment.Medical rationale and diagnostic prospects for major categories of both circulating and cellular tests, such as :   - Biochemical ...

  • Industries : Biological Therapy
Tissue Engineering: The Combination of Cells & Engineering - A Global Market Overview

Tissue Engineering: The Combination of Cells & Engineering - A Global Market Overview

  • $ 3 600
  • Industry report
  • February 2012
  • by Industry Experts

Advancements of novel therapies in the fields of tissue engineering and regenerative medicine have opened up new avenues for addressing a range of major diseases such as cancer; skin; cardiovascular conditions; ...

  • Industries : Biological Therapy
  • Countries : World, United States, Europe
Immunomodulators Market to 2017 - Immunosuppressant Antibodies to Replace Antimetabolites as the Highest Value Sector by 2017

Immunomodulators Market to 2017 - Immunosuppressant Antibodies to Replace Antimetabolites as the Highest Value Sector by 2017

  • $ 3 500
  • Industry report
  • February 2012
  • by GBI Research

Immunomodulators Market to 2017 - Immunosuppressant Antibodies to Replace Antimetabolites as the Highest Value Sector by 2017 Summary Leading business intelligence provider GBI Research has released its ...

  • Industries : Biological Therapy
  • Countries : World, United States, Europe
Isis Pharma and Biogen Idec Enter Global Collaboration on Antisense Program Targeting Spinal Muscular Atrophy - Deal Analysis from GlobalData

Isis Pharma and Biogen Idec Enter Global Collaboration on Antisense Program Targeting Spinal Muscular Atrophy - Deal Analysis from GlobalData

  • $ 500
  • Company report
  • January 2012
  • by Global Data

Isis Pharma and Biogen Idec Enter Global Collaboration on Antisense Program Targeting Spinal Muscular Atrophy - Deal Analysis from GlobalData Summary The report is an essential source of information and ...

  • Industries : Biological Therapy
  • Countries : World
U.S. Tissue Engineering Markets 

U.S. Tissue Engineering Markets 

  • $ 6 000
  • Industry report
  • January 2012
  • by Frost & Sullivan

The scope of this research service primarily includes tissue engineering products and companies in the wound care and surgery space. Surgery includes cardiovascular, orthopedics, neurology, organ regeneration, ...

  • Industries : Biological Therapy
  • Countries : United States
U.S. Tissue Engineering Markets

U.S. Tissue Engineering Markets

  • $ 6 000
  • Industry report
  • January 2012
  • by Frost & Sullivan

The scope of this research service primarily includes tissue engineering products and companies in the wound care and surgery space. Surgery includes cardiovascular, orthopedics, neurology, organ regeneration, ...

  • Industries : Biological Therapy
  • Countries : United States
Analysis of the Stem Cell Markets-Unlocking the New Era in Therapeutics 

Analysis of the Stem Cell Markets-Unlocking the New Era in Therapeutics 

  • $ 6 000
  • Industry report
  • January 2012
  • by Frost & Sullivan

This research service analyses the emerging stem cell therapeutics applications by geographic regions, encompassing Europe - The United Kingdom, Germany, Sweden, Belgium, Finland, France and Spain. The ...

  • Industries : Biological Therapy
  • Countries : Europe, United Kingdom, Sweden, Spain, France, Germany, Finland, Belgium
Delving into Stem Cell Research and its Potential

Delving into Stem Cell Research and its Potential

  • $ 350
  • Industry report
  • January 2012
  • by Aruvian's R'search

Stem cells are primal cells found in all multi-cellular organisms that retain the ability to renew themselves through mitotic cell division and can differentiate into a wide range of specialized cell types. ...

  • Industries : Biological Therapy
  • Countries : World, Australia, United States, United Kingdom, Europe, Canada, Germany, Japan, Israel, China
Strategic Development of Neural Stem & Progenitor Cell Products

Strategic Development of Neural Stem & Progenitor Cell Products

  • $ 3 495
  • Industry report
  • January 2012
  • by BioInformant Worldwide, L.L.C.

Terminology: Neurogenesis is the process by which neurons are created. This process is most active during pre-natal development when neurogenesis is responsible for populating the growing brain. Neural ...

  • Industries : Biological Therapy
  • Countries : United States
Oncology Devices Market to 2017 - Improved Efficiency, Shorter Treatment Times and Cost-Effectiveness to Boost the Brachytherapy Devices Segment

Oncology Devices Market to 2017 - Improved Efficiency, Shorter Treatment Times and Cost-Effectiveness to Boost the Brachytherapy Devices Segment

  • $ 3 500
  • Industry report
  • December 2011
  • by GBI Research

Oncology Devices Market to 2017 - Improved Efficiency, Shorter Treatment Times and Cost-Effectiveness to Boost the Brachytherapy Devices Segment Summary GBI Research's report, ?Oncology Devices Market ...

  • Industries : Biological Therapy
  • Countries : World, Australia, Brazil, Canada, Spain, Italy, Germany, Japan, India, China, France, United States, United Kingdom, Europe, Oceania, Asia, South America, North America
World Biological Therapy: Alpha-Mannosidosis - Pipeline Review, H2 2011

World Biological Therapy: Alpha-Mannosidosis - Pipeline Review, H2 2011

  • $ 500
  • Company report
  • December 2011
  • by Global Markets Direct

Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) ? Pipeline Review, H2 2011 Global Industries Direct's, 'Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) - Pipeline Review, H2 2011', provides ...

  • Industries : Biological Therapy
  • Countries : World
Strategic Analysis of the European Stem Cell Research Tools Market

Strategic Analysis of the European Stem Cell Research Tools Market

  • $ 6 500
  • Industry report
  • December 2011
  • by Frost & Sullivan

The primary objective of this study is to measure brand perceptions of tools and technologies currently at the forefront of stem cell research: bio-imaging and microscopy, cell biology tools, immunochemicals, ...

  • Industries : Biological Therapy
  • Countries : Europe
International Brachytherapy S.A. (EZBG) - Financial and Strategic SWOT Analysis Review

International Brachytherapy S.A. (EZBG) - Financial and Strategic SWOT Analysis Review

  • $ 250
  • Company report
  • December 2011
  • by Global Data

International Brachytherapy S.A. (IBT Bebig) is a Europe-based medical device company, focusing on cancer treatment by radiation technology. The company is engaged in the design, development and distribution ...

  • Industries : Biological Therapy
Biological Therapy Industry: Emerging Technologies: Stem cells

Biological Therapy Industry: Emerging Technologies: Stem cells

  • $ 3 800
  • Industry report
  • November 2011
  • by Datamonitor

About This Report Stem cell therapies will play an increasingly important role in the underserved field of regenerative medicine, as preclinical discoveries are translated into the clinical setting and ...

  • Industries : Biological Therapy

» View Public Reports

About 900 reports

Cell Culture Business (cell culture, cell therapy) in Thailand and The United States

  • Industry report
  • March 2014
  • 7 pages
  • by Research Paper

... cultured cells selected for high production of secondary metabolites (dicosmo and misawa, 1995). One way to increase the production level of secondary metabolites is by elicitation, which ...


» Read our Company Profiles

35 Companies

GlaxoSmithKline P.L.C.

United States

Bioheart Inc.

United States

StemCells Inc.

United States

Geron Corp.

United States

Osiris Therapeutics Inc.

United States

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.